NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Lubricating greases with or w/out additives
Petroleum oils & oils from bituminous minerals (other than crude), and productds therefrom containing 70% (by wt) or more of these oils, nes
Petroleum products, other
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
090960 - Lubricating grease noi
604 - Petroleum, lubricating grease (other than bulk)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
B - Construction materials: includes paint and related materials, prefabricated building, wood products, metal and composition mater
R - 65.0
Z - No special type of cargo code applicable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $1,221.72 to $2,036.21.. | |
| Does NSN 9150-00-965-2003 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Department Of The Army, Department Of The Air Force, U.s. Marine Corps, Department Of The Navy, Federal Aviation Administration, U.s. Coast Guard, Hungary, Poland, Brazil, Spain, Singapore, New Zealand, Republic Of Korea, Italy, Greece, and Turkey | |
| What is the NIIN of NSN 9150-00-965-2003? | |
| 009652003 or 00-965-2003 | |
| Does NSN 9150-00-965-2003 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 9150-00-965-2003? | |
| No solicitations for this NSN. | |
| When was this national stock number assigned to the federal catalog? | |
| Jan 01, 1960 | |
Routes of entry: inhalation: unknown skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: eye: may be mildly irritating.
skin: release during high pressure usage may result in injection of
oil into the skin causing local necrosis. Inhalation: not expected
to be a relevant route of expo sure; high temperature vapors
irritate respiratory tract. Ingestion: low level of toxicity.
chronic: skin disorders.
explanation of carcinogenicity: none of the compounds in this product is
listed by iarc, ntp, or osha as a carcinogen.
effects of overexposure: may cause eye, skin & respiratory tract
irritation. Local necrosis is evidenced by delayed onset of pain
and tissue damage a few hours following injection.
medical cond aggravated by exposure: pre-existing skin disorders may be
aggravated by exposure to this product.
First aid: inhalation: remove to fresh air. Give oxygen if breathing is
difficult. Get medical attention. Eye: flush with water for 15
minutes while holding eyelids open. Get medical attention. Skin:
wash with s oap & water/waterless cleaner. Remove contaminated
clothing. If irritation persists, get medical attention. Ingestion:
do not induce vomiting. In general, no treatment is required. Get
medical advice.
Hcc: v6
solubility in water: negligible
appearance and odor: dark brown liquid.No odor
Stability indicator/materials to avoid: yes
strong oxidizing agents
stability condition to avoid: high temperatures, sparks, and open flames
hazardous decomposition products: a mixture of airborne solid, liquid
particulates and gases (co) will evolve when this material
undergoes combustion.
Waste disposal methods: dispose of in an appropriate disposal facility
in compliance with local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: adipic acid; diisooctyl ester
cas: 1330-86-5
fraction by wt: 65-80%
other rec limits: none specified
ingred name: lithium 12 hydroxystearate
cas: 7620-77-1
fraction by wt: 10-20%
other rec limits: none specified
ingred name: molybdenum disulfide
cas: 1317-33-5
rtecs #: qa4697000
fraction by wt: 0-10%
other rec limits: none specified
ingred name: antimony dialkyldithiocarbamate
cas: 15991-76-1
fraction by wt:
other rec limits: none specified
osha pel: 0.5 mg sb/m3
acgih tlv: 0.5 mg sb/m3
ingred name: additives containing potassium triborate
fraction by wt:
other rec limits: none specified
ingred name: p,p'-dioctyldiphenylamine
cas: 101-67-7
rtecs #: jj8850000
fraction by wt:
other rec limits: none specified
ingred name: minor additives
fraction by wt:
other rec limits: none specified
Routes of entry: inhalation: unknown skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: acute: eye: may be mildly irritating.
skin: release during high pressure usage may result in injection of
oil into the skin causing local necrosis. Inhalation: not expected
to be a relevant route of expo sure; high temperature vapors
irritate respiratory tract. Ingestion: low level of toxicity.
chronic: skin disorders.
effects of overexposure: eyes/skin: irritation;inhal: respiratory tract
irrit;ingest: g.I.Track disturb,catharsis and diarrhea.
medical cond aggravated by exposure: pre-existing skin disorders may be
aggravated by exposure to this product.
First aid: inhalation: remove to fresh air. Give oxygen if breathing is
difficult. Get medical attention. Eye: flush with water for 15
minutes while holding eyelids open. Get medical attention. Skin:
wash with s oap & water/waterless cleaner. Remove contaminated
clothing. If irritation persists, get medical attention. Ingestion:
do not induce vomiting. In general, no treatment is required. Get
medical advice.
Hcc: v6
solubility in water: negligible
appearance and odor: smooth buttery black grease with slight odor.
Stability indicator/materials to avoid: yes
strong oxidizing agents
stability condition to avoid: high temperatures, sparks, and open flames
hazardous decomposition products: a mixture of airborne solid, liquid
particulates and gases (co) will evolve when this material
undergoes combustion.
Waste disposal methods: dispose of in an appropriate disposal facility
in compliance with local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: synthetic ester
fraction by wt: >74%
ingred name: lithium based soap thickener
fraction by wt:
acgih tlv: not specified
ingred name: other components (unidentified)
fraction by wt:
acgih tlv: not specified
Ld50 lc50 mixture: ld50 (oral, rat) is unknown.
routes of entry: inhalation: no skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: target organs: eye, skin. Acute-
eye: direct contact irritates slightly. Skin: prolonged/repeated
contact may cause irritation. Injection under skin causes local
necrosis. Inhale: unlikely at ambient cond itions. Oral: low order of
toxicity. Chronic- may cause dermatitis.
explanation of carcinogenicity: this compound contains no ingredients at
concentrations of 0.1% or greater that are carcinogens or suspect
carcinogens.
effects of overexposure: irritation, redness, nausea, vomiting, delayed
onset of pain and tissue damage a few hours following injection
medical cond aggravated by exposure: individuals with pre-existing skin
disorders may be more succeptible to the effects from exposure to
this product.
First aid: get medical help if symptoms persist. Inhaled: remove to fresh
air. Eyes: flush with water for 15 minutes. Hold eyelids open.
skin: wipe off excess & wash skin with mild soap & water or
waterless cleaner . If injected under skin, regardless ofits size,
contact a physician immediately. Do not wait for symptoms to
develop. Oral: no first aid needed. However, get medical advice.
Hcc: v6
nrc/state lic num: not relevant
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: not given
decomp temp: decomp text: not given
vapor pres: not given
vapor density: not given
spec gravity: not given
evaporation rate & reference: not given
solubility in water: insoluble
appearance and odor: dark grey, smooth grease - slight odor
Stability indicator/materials to avoid: yes
strong oxidizing agents
stability condition to avoid: excessive heat, open flame
hazardous decomposition products: a complex mixture of airborne solid,
liquid, particulates & gases will evovle. Carbon monoxide & other
compd. May form.
Waste disposal methods: dispose of in accordance with all local, state
and federal regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: azelaic acid, bis(2-ethylhexyl) ester/synthetic ester
cas: 103-24-2
rtecs #: cm2000000
fraction by wt: 82%
other rec limits: none recommended
ingred name: bentonite/inorganic clay
cas: 1302-78-9
rtecs #: ct9450000
fraction by wt: 6%
other rec limits: none recommended
osha pel: 5 mg/m3 (dust)
acgih tlv: 5 mg/m3 (dust)
ingred name: molybdenum disulfide
cas: 1317-33-5
rtecs #: qa4697000
fraction by wt: 5%
other rec limits: none recommended
osha pel: 10 mg mo/m3
acgih tlv: 10 mg mo/m3
ingred name: fatty acid amides
cas: 68910-93-0
fraction by wt: 3%
other rec limits: none recommended
ingred name: other components
fraction by wt: 4%
other rec limits: none recommended
Ld50 lc50 mixture: not specified by manufacturer.
routes of entry: inhalation: no skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: may be slightly irritating to eyes.
prolonged and/or repeated contact amay cause various skin disorders
such as dermatits, folliculitis or oil acne. Release during high
pressure usuage may result in i njection of oil into the skin
causing local necrosis.
explanation of carcinogenicity: this compound contains no ingredients at
concentrations of 0.1% or greater that are carcinogens or suspect
carcinogens.
effects of overexposure: eye irritation, skin irritation, dermatitis,
folliculitis, oil acne. Local necrosis is evidenced by delayed
onset of pain and tissue damage a few hours following injection.
medical cond aggravated by exposure: pre-existing eye and skin disorders
may be aggravated by exposure to this product.
First aid: inhalation: remove from exposure. Restore breathing. Keep
warm and quiet. Get medical attention. Skin: wash affected area
thoroughly with soap and water. If irritation persists, get medical
attention. If material is injected under the skin, get medical
attention promptly. Eyes: flush with large amounts of water for 15
minutes. Get medical attention. Ingestion: do not induce vomiting.
get doctor.
Hcc: v6
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: not given
vapor pres: not given
vapor density: not given
spec gravity: 0.89
evaporation rate & reference: nil
solubility in water: negligible
appearance and odor: smooth buttery black grease, hydrocarbon odor
Stability indicator/materials to avoid: yes
strong oxidizers
stability condition to avoid: avoid heat, flame
hazardous decomposition products: carbon monoxide and other unidentified
organic compounds may be formed upon combustion.
Waste disposal methods: prevent waste from contaminating surrounding
environment. Discard any product, residue, disposal container or
liner in accordance with all federal, state and local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: adipic acid; diisooctyl ester
cas: 1330-86-5
fraction by wt: 70-80%
other rec limits: none recommended
ingred name: molybdenum disulfide
cas: 1317-33-5
rtecs #: qa4697000
fraction by wt: 3-7% %
other rec limits: none recommended
osha pel: 15 mg/m3
acgih tlv: 10 mg/m3
ingred name: acetic acid, calcium salt
cas: 62-54-4
rtecs #: af7525000
fraction by wt: < 3.0%
other rec limits: none recommended
ingred name: lithium 12 hydroxystearate
cas: 7620-77-1
fraction by wt: 10-15% %
other rec limits: none recommended
ingred name: non hazardous ingredients
fraction by wt: < 5.0%
other rec limits: none recommended
Ld50 lc50 mixture: ld50 (oral, rat) is unknown.
routes of entry: inhalation: no skin: yes ingestion: no
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: target organs: eye, skin. Acute-
eye: direct contact irritates slightly. Skin: prolonged/repeated
contact may cause irritation, dermatitis, foliculitis or oil acne.
injection under skin causes local necr osis. Inhale: unlikely at
ambient conditions. Oral: low order of toxicity. Chronic- may cause
dermatitis.
explanation of carcinogenicity: this compound contains no ingredients at
concentrations of 0.1% or greater that are carcinogens or suspect
carcinogens.
effects of overexposure: irritation, redness, nausea, vomiting, delayed
onset of pain and tissue damage a few hours following injection
medical cond aggravated by exposure: individuals with pre-existing skin
disorders may be more succeptible to the effects from exposure to
this product.
First aid: get medical help if symptoms persist. Inhaled: remove to fresh
air. Eyes: flush with water for 15 minutes. Hold eyelids open.
skin: wipe off excess & wash skin with mild soap & water or
waterless cleaner . If injected under skin, regardless ofits size,
contact a physician immediately. Do not wait for symptoms to
develop. Oral: no first aid needed. However, get medical advice.
Hcc: v6
nrc/state lic num: not relevant
boiling pt: b.P. Text: not given
melt/freeze pt: m.P/f.P text: not given
decomp temp: decomp text: not given
vapor pres: not given
vapor density: not given
spec gravity: not given
evaporation rate & reference: not given
solubility in water: insoluble
appearance and odor: dark grey, smooth grease - slight odor
Stability indicator/materials to avoid: yes
strong oxidizing agents
stability condition to avoid: excessive heat, open flame
hazardous decomposition products: a complex mixture of airborne solid,
liquid particulates & gases will evovle when this product undergoes
pyrolysis or combustion. Carbon monoxide & unidentified organic
compounds may be formed upon.
Waste disposal methods: dispose of in accordance with all local, state
and federal regulations.
Ingred name: azelaic acid, bis(2-ethylhexyl) ester/synthetic ester
cas: 103-24-2
rtecs #: cm2000000
fraction by wt: 82%
other rec limits: none recommended
ingred name: bentonite/inorganic clay
cas: 1302-78-9
rtecs #: ct9450000
fraction by wt: 6%
other rec limits: none recommended
osha pel: 5 mg/m3 (dust)
acgih tlv: 5 mg/m3 (dust)
ingred name: molybdenum disulfide
cas: 1317-33-5
rtecs #: qa4697000
fraction by wt: 5%
other rec limits: none recommended
osha pel: 10 mg mo/m3
acgih tlv: 10 mg mo/m3
ingred name: fatty acid amides
cas: 68910-93-0
fraction by wt: 3%
other rec limits: none recommended
ingred name: other components
fraction by wt: 4%
other rec limits: none recommended